Insight into Smead Value Fund (Trades, Portfolio)'s Latest Investment Decisions Warning! GuruFocus has detected 4 Warning Signs with SPG. Smead Value Fund (Trades, Portfolio) recently submitted its N-PORT filing for the first quarter of 2025, shedding light on its strategic investment decisions during this period. Smead Capital Management, the adviser to the Smead Value Fund (Trades, Portfolio), caters to a diverse clientele, including individuals, advisors, family offices, and institutions worldwide. The fund primarily invests in U.S. large-cap companies and offers various share classes, including Investor Share Class (SMVLX) and A Share Class (SVFAX), among others. Managed by Lead Portfolio Manager Bill Smead and Co-Portfolio Manager Cole Smead, CFA, the fund aims for long-term capital appreciation through concentrated positions, typically holding 25-30 companies. Smead's investment philosophy focuses on eight criteria, including economic need, competitive advantage, profitability, and shareholder-friendly management.Smead Value Fund's Strategic Move: Millrose Properties Inc. Takes Center Stage Summary of New Buy Smead Value Fund (Trades, Portfolio) added a total of one stock to its portfolio this quarter: The most significant addition was Millrose Properties Inc (NYSE:MRP), with 1,081,478 shares, accounting for 0.46% of the portfolio and a total value of $24.72 million. Key Position Increases Smead Value Fund (Trades, Portfolio) also increased its stakes in one stock: The most notable increase was in Merck & Co Inc (NYSE:MRK), with an additional 139,193 shares, bringing the total to 3,034,166 shares. This adjustment represents a significant 4.81% increase in share count, a 0.24% impact on the current portfolio, with a total value of $279.90 million. Key Position Reduces Smead Value Fund (Trades, Portfolio) reduced its position in 27 stocks. The most significant changes include: Reduced Simon Property Group Inc (NYSE:SPG) by 117,876 shares, resulting in a -5.25% decrease in shares and a -0.36% impact on the portfolio. The stock traded at an average price of $177.83 during the quarter and has returned -8.62% over the past 3 months and -6.81% year-to-date. Reduced Lennar Corp (NYSE:LEN) by 119,929 shares, resulting in a -5.25% reduction in shares and a -0.35% impact on the portfolio. The stock traded at an average price of $131.81 during the quarter and has returned -19.83% over the past 3 months and -13.61% year-to-date. Portfolio Overview As of the first quarter of 2025, Smead Value Fund (Trades, Portfolio)'s portfolio included 30 stocks. The top holdings were 7.41% in Simon Property Group Inc (NYSE:SPG), 6.3% in American Express Co (NYSE:AXP), 5.6% in Macerich Co (NYSE:MAC), 5.49% in Amgen Inc (NASDAQ:AMGN), and 5.24% in Merck & Co Inc (NYSE:MRK). Story Continues Smead Value Fund's Strategic Move: Millrose Properties Inc. Takes Center Stage The holdings are mainly concentrated in 9 of the 11 industries: Financial Services, Energy, Consumer Cyclical, Real Estate, Healthcare, Consumer Defensive, Industrials, Technology, and Communication Services.Smead Value Fund's Strategic Move: Millrose Properties Inc. Takes Center Stage This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus. View Comments
Smead Value Fund's Strategic Move: Millrose Properties Inc. Takes Center Stage
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...